Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7zm55 | — |
administered 2 adjuvants (1ml total) to a patient and did not put powder (antigen) component into liquid; administered 2 adjuvants (1ml total) to a patient and did not put powder (antigen) component into liquid; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 7zm55, expiry date 15-NOV-2026) for prophylaxis. On 11-FEB-2025, the patient received Shingrix. On 11-FEB-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administered 2 adjuvants (1ml total) to a patient and did not put powder (antigen) component into liquid) and inappropriate dose of vaccine administered (Verbatim: administered 2 adjuvants (1ml total) to a patient and did not put powder (antigen) component into liquid). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK receipt date: 12-FEB-2025 The LPN (Licensed practical nurses) reported that day before reporting that the MA(Medical assistant) administered two adjuvants (1ml total) to a patient and did not put powder (antigen) component into liquid which led to, inappropriate preparation of medication and inappropriate dose of vaccine administered.